VivoSeq
Other

Learning Disability

2

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Learning Disability is an early-stage landscape with 2 programs across 1 company. The most active players are Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA). 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

50/100

Completion Rate

N/A

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

C

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

2

clinical trials

Unknown status1 · 50%
Recruiting1 · 50%

Clinical Trials

Trial Activity

Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study
Unknown status·—·N/A·NCT00956696·50 enrolled
Interventions in Math Learning Disabilities: Cognitive and Neural Correlates
Recruiting·SStanford University·Preclinical·NCT05201534·180 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)